Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit
Preeclampsia is a major pregnancy complication with adverse short- and long-term implications for both the mother and baby. Screening for preeclampsia at 11-13 weeks ’ gestation by a combination of maternal demographic characteristics and medical history with measurements of biomarkers can identify about 75% of women that develop preterm-preeclampsia with delivery at
Source: American Journal of Obstetrics and Gynecology - Category: OBGYN Authors: David Wright, Daniel L. Rolnik, Argyro Syngelaki, Catalina de Paco Matallana, Mirian Machuca, Mercedes de Alvarado, Sofia Mastrodima, Min Yi Tan, Siobhan Shearing, Nicola Persico, Jacques C. Jani, Walter Plasencia, George Papaioannou, Francisca S. Molina, Tags: Original Research: Obstetrics Source Type: research
More News: Aspirin | Babies | Intensive Care | OBGYN | Perinatology & Neonatology | Pregnancy | Women